Adrian F. Hernandez

@texhern

Father of 4 boys, cardiologist, clinical researcher- outcomes, clinical trials, health policy & innovative methods

Duke University
Vrijeme pridruživanja: ožujak 2011.

Tweetovi

Blokirali ste korisnika/cu @texhern

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @texhern

  1. 1. velj

    Who will be the next founder of a major science or tech company? I’m sure they are in this room... world will be better with these kids

    Poništi
  2. 29. sij
    Poništi
  3. proslijedio/la je Tweet
    22. sij
    Poništi
  4. 15. sij
    Poništi
  5. 10. sij
    Poništi
  6. 27. pro 2019.

    Many would say more randomized clinical trial data are still needed to prove benefits of digital therapeutics ...

    Poništi
  7. 19. pro 2019.
    Poništi
  8. 15. pro 2019.

    Great time by all! Thx for hosting. Now we know plan B for the group - !

    Poništi
  9. proslijedio/la je Tweet

    Great piece on accidental study w most definitive evidence that insurance saves lives. Govt randomly mailed 3.9M uninsured a notice of how to get coverage and left 600k out for lack of $. Result at 2 yrs: gaining coverage = 12% lower death rate.

    Poništi
  10. 12. pro 2019.
    Poništi
  11. 10. pro 2019.

    Thanks so much for changing the landscape on what should be

    Poništi
  12. proslijedio/la je Tweet
    9. pro 2019.

    How will a new study use PCORnet to assess the effectiveness of statins to prevent dementia and other health problems in older adults without ? Read more here.

    Poništi
  13. proslijedio/la je Tweet

    Current estimate is that it takes $2billion to get a drug approved (includes opportunity cost)

    Poništi
  14. proslijedio/la je Tweet

    Here is the Institute of Medicines recommendations on how to proceed in developing drugs and devices. Please comment

    Poništi
  15. proslijedio/la je Tweet

    Summary of his perspective from Adrian Hernandez at Duke

    Poništi
  16. proslijedio/la je Tweet

    Adrian Hernandez using the term “Monitoring Terrorism” regarding the ever expanding scope and cost of monitoring; monitoring occupies 40% of a clinical trial’s budget

    Poništi
  17. 6. pro 2019.

    Another example of what clinical trials can do- bring the international community together! Collaboration to improve the health of patients- listening to the French ambassador, phillippe etienne

    Poništi
  18. 5. pro 2019.
    Poništi
  19. 5. pro 2019.

    Other ways to evaluate the total patient journey for diabetes trials

    Poništi
  20. 5. pro 2019.

    Darren McGuire raises the question- can we do 3x size trials for non inferiority trials? Or is cost prohibitive?

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·